Li-Tzong Chen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Top Venues

Cancer research communications

Journal of biomedical science

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Siao Muk Cheng, Yung-Yeh Su, Nai-Jung Chiang, Chih-Jung Wang, Ying-Jui Chao, Chien-Jui Huang, Hui-Jen Tsai, Shang-Hung Chen, Chi-Yen Chang, Chia-Rung Tsai, Yi-Jie Li, Chia-Jui Yen, Shih-Chang Chuang, Jeffrey Shu-Ming Chang, Yan-Shen Shan, Daw-Yang Hwang, Li-Tzong Chen
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. Journal of biomedical science 31 (1) (2024)
Siao Muk Cheng, Yung-Yeh Su, Nai-Jung Chiang, Chih-Jung Wang, Ying-Jui Chao, Chien-Jui Huang, Hui-Jen Tsai, Shang-Hung Chen, Chi-Yen Chang, Chia-Rung Tsai, Yi-Jie Li, Chia-Jui Yen, Shih-Chang Chuang, Jeffrey Shu-Ming Chang, Yan-Shen Shan, Daw-Yang Hwang, Li-Tzong Chen
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. Journal of biomedical science 31 (1) (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase 1 Study of KIN-3248, an irreversible small molecule pan-FGFR inhibitor, in Patients with Advanced FGFR 2/3 Driven Solid Tumors. Cancer research communications (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Siao Muk Cheng, Yung-Yeh Su, Nai-Jung Chiang, Chih-Jung Wang, Ying-Jui Chao, Chien-Jui Huang, Hui-Jen Tsai, Shang-Hung Chen, Chi-Yen Chang, Chia-Rung Tsai, Yi-Jie Li, Chia-Jui Yen, Shih-Chang Chuang, Jeffrey Shu-Ming Chang, Yan-Shen Shan, Daw-Yang Hwang, Li-Tzong Chen
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. Journal of biomedical science 31 (1) (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Chih-Chieh Yen, Yi-Hsin Yang, Hsiu-Ying Ku, Huang-Ming Hu, Su-Shun Lo, Hung-Chi Chang, Yee Chao, Jen-Shi Chen, Hsiu-Po Wang, Tsang-En Wang, Li-Yuan Bai, Ming-Shiang Wu, Chia-Jui Yen, Li-Tzong Chen, Yan-Shen Shan
The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study. Cancer medicine (2023)
Chi-Feng Tseng, Li-Tzong Chen, Horng-Dar Wang, Yi-Hong Liu, Shine-Gwo Shiah
Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness. Cancer science 113 (5) (2022)
Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, Chin-Fu Hsiao, Chung-Yu Huang, Yi-Ping Hung, Chien-Jui Huang, San-Chi Chen, Yan-Shen Shan, Yee Chao, Yi-Hsiang Huang, I-Cheng Lee, Pei-Chang Lee, Yung-Yeh Su, Shu-Jen Chen, Chun-Nan Yeh, Li-Tzong Chen, Ming-Huang Chen
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Yung-Yeh Su, Yen-Feng Chiu, Chung-Pin Li, Shih-Hung Yang, Johnson Lin, Shyh-Jer Lin, Ping-Ying Chang, Nai-Jung Chiang, Yan-Shen Shan, Hui-Ju Ch'ang, Li-Tzong Chen
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study. British journal of cancer 126 (7) (2021)
Nai-Jung Chiang, Ming-Huang Chen, Shih-Hung Yang, Chiun Hsu, Chia-Jui Yen, Hsiao-Hui Tsou, Yung-Yeh Su, Jen-Shi Chen, Yan-Shen Shan, Li-Tzong Chen
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)
Tsung-Ming Chang, Pei-Yi Chu, Wen-Chun Hung, Yan-Shen Shan, Hui-You Lin, Kuo-Wei Huang, Jeffrey S Chang, Li-Tzong Chen, Hui-Jen Tsai
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation. Cancer science 112 (1) (2020)
Yung-Jue Bang, Chung-Pin Li, Kyung-Hun Lee, Chang-Fang Chiu, Joon Oh Park, Yan-Shen Shan, Jun Suk Kim, Jen-Shi Chen, Hyun-Jeong Shim, Kun-Ming Rau, Hye Jin Choi, Do-Youn Oh, Bruce Belanger, Li-Tzong Chen
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study. Cancer science 111 (2) (2019)